RetinalGeniX is an emerging medical device company focused on commercializing the next generation of cost-effective, ultra-wide imaging technologies to examine the periphery of the retina, at up to a 200° field of view, to detect early signs of diabetic retinopathy without having to dilate a patient's pupil.

There is a dire need for a simpler and more affordable device and method that allows for an uncomplicated but accurate imaging of a person’s retina to detect symptoms of diabetic retinopathy.

Subscribe for News

Keep me posted about RetinalGeniX